NCT06823778 Prophylactic Radiofrequency Left Atrial Posterior Wall Isolation to Prevent Atrial Fibrillation After Cardiac Surgery
| NCT ID | NCT06823778 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Vasily I. Kaleda |
| Condition | Postoperative Atrial Fibrillation |
| Study Type | INTERVENTIONAL |
| Enrollment | 216 participants |
| Start Date | 2025-02-17 |
| Primary Completion | 2027-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 216 participants in total. It began in 2025-02-17 with a primary completion date of 2027-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if an epicardial radiofrequency left atrial posterior wall isolation (box lesion ablation) prevents atrial fibrillation after cardiac surgery. The main question it aims to answer is: \- Does box lesion ablation lower the number of patients experiencing de-novo atrial fibrillation requiring any treatment after cardiac surgery? Researchers will compare box lesion ablation to no ablation to see if ablation prevents postoperative atrial fibrillation. Participants will undergo ablation or no ablation at the time of other cardiac surgery. Data will be collected while in hospital. Additional information will be collected on 30th day after surgery by telephone call or during a visit.
Eligibility Criteria
Inclusion Criteria: * All patients undergoing cardiac surgery by a single surgeon (V.K.) * Informed consent Exclusion Criteria: * History of atrial fibrillation/flutter * Minimally invasive approach * Off-pump surgery * Emergent/salvage surgery * Severe pericardial adhesions
Contact & Investigator
Alexandr Piskun, M.D., Ph.D.
STUDY CHAIR
Yudin Hospital
Frequently Asked Questions
Who can join the NCT06823778 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Postoperative Atrial Fibrillation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06823778 currently recruiting?
Yes, NCT06823778 is actively recruiting participants. Contact the research team at vasily.kaleda@gmail.com for enrollment information.
Where is the NCT06823778 trial being conducted?
This trial is being conducted at Moscow, Russia.
Who is sponsoring the NCT06823778 clinical trial?
NCT06823778 is sponsored by Vasily I. Kaleda. The principal investigator is Alexandr Piskun, M.D., Ph.D. at Yudin Hospital. The trial plans to enroll 216 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.